Fujii; Nobutaka
Patent Applications and Registrations
Patent applications and USPTO patent grants for Fujii; Nobutaka.The latest application filed is for "tgf-beta signal transduction inhibitor".
- Fujii; Nobutaka - Shiga N/A JP
- Fujii; Nobutaka - Kyoto N/A JP
- Fujii; Nobutaka - Ohtsu JP
- Fujii; Nobutaka - Ohtsu-shi JP
- Fujii; Nobutaka - Otsu JP
- Fujii; Nobutaka - Otsu-shi JP
- Fujii, Nobutaka - Ohginosato-higashi JP
- Fujii; Nobutaka - Osaka JP
- Fujii; Nobutaka - Hirakata JP
| Patent | Date |
|---|---|
| CXCR4 antagonists for wound healing and re-epithelialization Grant 9,034,814 - Peled , et al. May 19, 2 | 2015-05-19 |
| TGF-.beta. signal transduction inhibitor Grant 8,772,297 - Kakeya , et al. July 8, 2 | 2014-07-08 |
| Metastin derivative and use thereof Grant 8,592,379 - Fujii , et al. November 26, 2 | 2013-11-26 |
| Polypeptide anti-HIV agent containing the same Grant 8,435,939 - Fujii May 7, 2 | 2013-05-07 |
| CXCR4 antagonist and use thereof Grant 8,410,059 - Fujii , et al. April 2, 2 | 2013-04-02 |
| TGF-beta SIGNAL TRANSDUCTION INHIBITOR App 20130045977 - Kakeya; Hideaki ; et al. | 2013-02-21 |
| Compound having GPR54 agonistic activity Grant 8,183,212 - Fujii , et al. May 22, 2 | 2012-05-22 |
| Cxcr4 Antagonist And Use Thereof App 20110269686 - FUJII; Nobutaka ; et al. | 2011-11-03 |
| CXCR4 antagonist and use thereof Grant 8,017,585 - Fujii , et al. September 13, 2 | 2011-09-13 |
| Metastin Derivative And Use Thereof App 20110039786 - Fujii; Nobutaka ; et al. | 2011-02-17 |
| Method For Production Of N36-binding Peptide App 20110014649 - Tsutsumi; Hiroko ; et al. | 2011-01-20 |
| Novel polypeptide anti-HIV agent containing the same App 20100222256 - Fujii; Nobutaka | 2010-09-02 |
| Novel Compound Having Gpr54 Agonistic Activity App 20100160241 - Fujii; Nobutaka ; et al. | 2010-06-24 |
| CXCR4 Antagonists for Wound Healing and Re-Epithelialization App 20100055088 - Peled; Amnon ; et al. | 2010-03-04 |
| Polypeptides having anti-HIV activity and compositions comprising same Grant 7,595,298 - Fujii September 29, 2 | 2009-09-29 |
| Cxcr4 Antagonist And Use Thereof App 20090181897 - Fujii; Nobutaka ; et al. | 2009-07-16 |
| Anti-coronavirus drug Grant 7,495,011 - Fujii , et al. February 24, 2 | 2009-02-24 |
| Novel CXCR4 Antagonist and Use Thereof App 20090036416 - Fujii; Nobutaka ; et al. | 2009-02-05 |
| Cxcr4 antagonist and use thereof Grant 7,423,007 - Fujii , et al. September 9, 2 | 2008-09-09 |
| Cxcr4 antagonist and use thereof App 20060264378 - Fujii; Nobutaka ; et al. | 2006-11-23 |
| Polypeptides having anti-HIV activity and compositions comprising same App 20060264605 - Fujii; Nobutaka | 2006-11-23 |
| Polypeptides having anti-HIV activity and compositions comprising same Grant 7,138,488 - Fujii November 21, 2 | 2006-11-21 |
| Anti-coronavirus drug App 20060223847 - Fujii; Nobutaka ; et al. | 2006-10-05 |
| Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A Grant 6,855,323 - Scherf , et al. February 15, 2 | 2005-02-15 |
| Metastin derivatives and their use Grant 6,800,611 - Fujii , et al. October 5, 2 | 2004-10-05 |
| Metastin derivatives and their use App 20040142875 - Fujii, Nobutaka ; et al. | 2004-07-22 |
| Novel polypeptides and anti-hiv drugs containing the same App 20040116655 - Fujii, Nobutaka | 2004-06-17 |
| Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A App 20040062769 - Scherf, Arthur ; et al. | 2004-04-01 |
| Compounds with antitumor activity Grant 6,545,125 - Fujii April 8, 2 | 2003-04-08 |
| Polypeptides with affinity to lipopolysaccharides and their uses Grant 5,449,752 - Fujii , et al. September 12, 1 | 1995-09-12 |
| Calcitonin gene related peptide derivatives Grant 4,743,677 - Noda , et al. May 10, 1 | 1988-05-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 